MedTrace Logo

Neuropsychological Evaluation for Early Diagnosis of PSP

NCT03478124 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2018-03-27

No results posted yet for this study

Summary

The aim of this study is to better understand the nature of the cognitive decline in Progressive Supranuclear Palsy, the time of its development and the relation with the other cardinal features of the disease.

Conditions

Interventions

BEHAVIORAL

Cognitive evaluation

An extensive battery of neuropsychological and motor tests was assessed: MMSE, FAB, MoCA, WCST, Stroop Test, TMT-A and B, Verbal fluency Test, ROCF copy and delayed recall, RAVLT, 6MWT, TUG, BBS.

Sponsors & Collaborators

  • Ospedale Generale Di Zona Moriggia-Pelascini

    lead OTHER

Principal Investigators

  • Giuseppe Frazzitta, MD · Department of Parkinson's disease, Movement Disorders and Brain Injury Rehabilitation, "Moriggia-Pelascini" Hospital - Via Pelascini, 3, 22015, Gravedona ed Uniti, Como, Italy

Eligibility

Sex
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2018-03-01
Completion
2018-03-02

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03478124 on ClinicalTrials.gov